

HY-170928 · 50 mg
MedChemExpress · Cat: HY-170928
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/da-0157.html
Description
DA-0157 is the orally active inhibitor for EGFR and ALK that overcomes drug-resistant mutations of EGFR C797S and ALK in NSCLC cells. DA-0157 inhibits the proliferation of Ba/F3-EGFR Del19/T790M/C797S IC50 = 6.9 nM , Ba/F3-EGFR WT IC50 = 0.83 ?M , Ba/F3-EML4-ALK-L1196M IC50 = 5.5 nM , and Ba/F3-EML4-ALK IC50 = 7.4 nM . DA-0157 inhibits CYP2D6 with IC50 of 5.26 ?M. DA-0157 exhibits antitumor efficacy in mouse models.







